Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/558| Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19 | |
| Mingyue Li Haijun Wang Weina Guo Haifeng Zhou Rui Zhu Li Wang Lei Zhao Heng Fan Shanshan Luo Desheng Hu | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| https://doi.org/10.1016/j.numecd.2020.04.013 | |
| Prognosis Cardiovascular disease COVID-19 | |
| A novel coronavirus severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) caused pneumonia, Coronavirus Disease 2019 (COVID-19), outbroke in Wuhan, China in December 2019, and spread all over the world. Patients with COVID-19 showed huge differences in the hospital stays, progression and prognosis. As reported, the comorbidities may play an important role in COVID-19. Here, we aim to address the role of cardiovascular disease (CVD) in the progression and prognosis of COVID-19. | |
| Nutrition, Metabolism and Cardiovascular Diseases | |
| 2020 | |
| Preimpreso | |
| https://www.sciencedirect.com/science/article/pii/S0939475320301344#! | |
| Inglés | |
| Epidemia COVID-19 | |
| Investigadores | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos: